Search

Jean F. Voltaire

Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )

Most Active Art Unit
2466
Art Unit(s)
2466, 2417
Total Applications
487
Issued Applications
381
Pending Applications
55
Abandoned Applications
68

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11090596 [patent_doc_number] => 20160287564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/085451 [patent_app_country] => US [patent_app_date] => 2016-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23894 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15085451 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/085451
METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS Mar 29, 2016 Abandoned
Array ( [id] => 11016718 [patent_doc_number] => 20160213671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'PROPHYLAXIS AND TREATMENT OF A NEURODEGENERATIVE DISEASE NOT BASED ON A PROTEIN-FOLDING DISORDER' [patent_app_type] => utility [patent_app_number] => 15/082409 [patent_app_country] => US [patent_app_date] => 2016-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3534 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082409 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/082409
Prophylaxis and treatment of a neurodegenerative disease not based on a protein-folding disorder Mar 27, 2016 Issued
Array ( [id] => 11082177 [patent_doc_number] => 20160279142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND A CDK4/6 INHIBITOR COMPOUND FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/080019 [patent_app_country] => US [patent_app_date] => 2016-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16768 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080019 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/080019
COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND A CDK4/6 INHIBITOR COMPOUND FOR THE TREATMENT OF CANCER Mar 23, 2016 Abandoned
Array ( [id] => 11804436 [patent_doc_number] => 09545398 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-01-17 [patent_title] => 'Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide' [patent_app_type] => utility [patent_app_number] => 15/078911 [patent_app_country] => US [patent_app_date] => 2016-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16116 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15078911 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/078911
Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide Mar 22, 2016 Issued
Array ( [id] => 11082129 [patent_doc_number] => 20160279094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'DIETARY AND NATURAL PRODUCT MANAGEMENT OF NEGATIVE SIDE EFFECTS OF CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 15/078590 [patent_app_country] => US [patent_app_date] => 2016-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11091 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15078590 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/078590
Dietary and natural product management of negative side effects of cancer treatment Mar 22, 2016 Issued
Array ( [id] => 11002345 [patent_doc_number] => 20160199294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'SUBLINGUAL NALOXONE SPRAY' [patent_app_type] => utility [patent_app_number] => 15/076080 [patent_app_country] => US [patent_app_date] => 2016-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14435 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15076080 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/076080
SUBLINGUAL NALOXONE SPRAY Mar 20, 2016 Abandoned
Array ( [id] => 10987335 [patent_doc_number] => 20160184280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'METHODS OF PREVENTING THE DEVELOPMENT OF MUCOSITIS AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/063256 [patent_app_country] => US [patent_app_date] => 2016-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8968 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15063256 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/063256
METHODS OF PREVENTING THE DEVELOPMENT OF MUCOSITIS AND RELATED DISORDERS Mar 6, 2016 Abandoned
Array ( [id] => 11002416 [patent_doc_number] => 20160199365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => '2-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative Diseases' [patent_app_type] => utility [patent_app_number] => 15/059395 [patent_app_country] => US [patent_app_date] => 2016-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13713 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15059395 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/059395
2-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative Diseases Mar 2, 2016 Abandoned
Array ( [id] => 12404910 [patent_doc_number] => 09968565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Method for protection and improvement of liver health with meso-zeaxanthin compositions [patent_app_type] => utility [patent_app_number] => 15/058823 [patent_app_country] => US [patent_app_date] => 2016-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 10 [patent_no_of_words] => 7457 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15058823 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/058823
Method for protection and improvement of liver health with meso-zeaxanthin compositions Mar 1, 2016 Issued
Array ( [id] => 11348778 [patent_doc_number] => 20160367518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS' [patent_app_type] => utility [patent_app_number] => 15/057017 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16434 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15057017 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/057017
METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS Feb 28, 2016 Abandoned
Array ( [id] => 11879569 [patent_doc_number] => 09750724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-05 [patent_title] => 'Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases' [patent_app_type] => utility [patent_app_number] => 15/050394 [patent_app_country] => US [patent_app_date] => 2016-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16909 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050394 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/050394
Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases Feb 21, 2016 Issued
Array ( [id] => 11047489 [patent_doc_number] => 20160244447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/047717 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41627 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047717 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/047717
Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof Feb 18, 2016 Issued
Array ( [id] => 11047497 [patent_doc_number] => 20160244455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME' [patent_app_type] => utility [patent_app_number] => 15/048007 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 51596 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15048007 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/048007
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme Feb 18, 2016 Issued
Array ( [id] => 11047489 [patent_doc_number] => 20160244447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/047717 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41627 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047717 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/047717
Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof Feb 18, 2016 Issued
Array ( [id] => 11047489 [patent_doc_number] => 20160244447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/047717 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41627 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047717 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/047717
Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof Feb 18, 2016 Issued
Array ( [id] => 12165302 [patent_doc_number] => 09884060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-06 [patent_title] => 'KIF5B-RET fusion molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 15/045716 [patent_app_country] => US [patent_app_date] => 2016-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 43232 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15045716 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/045716
KIF5B-RET fusion molecules and uses thereof Feb 16, 2016 Issued
Array ( [id] => 12098132 [patent_doc_number] => 09855215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Methotrexate composition' [patent_app_type] => utility [patent_app_number] => 15/019244 [patent_app_country] => US [patent_app_date] => 2016-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4520 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019244 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/019244
Methotrexate composition Feb 8, 2016 Issued
Array ( [id] => 10797722 [patent_doc_number] => 20160143878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'ANTIBACTERIAL AGENT' [patent_app_type] => utility [patent_app_number] => 15/017932 [patent_app_country] => US [patent_app_date] => 2016-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16616 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017932 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/017932
ANTIBACTERIAL AGENT Feb 7, 2016 Abandoned
Array ( [id] => 14143039 [patent_doc_number] => 10251871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-09 [patent_title] => Compositions and methods for treatment of edema [patent_app_type] => utility [patent_app_number] => 15/549156 [patent_app_country] => US [patent_app_date] => 2016-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 23784 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549156 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/549156
Compositions and methods for treatment of edema Feb 4, 2016 Issued
Array ( [id] => 12151492 [patent_doc_number] => 20180022756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'COMPOUNDS AND METHODS FOR PREVENTING OR TREATING SENSORY HAIR CELL DEATH' [patent_app_type] => utility [patent_app_number] => 15/547438 [patent_app_country] => US [patent_app_date] => 2016-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 48951 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547438 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/547438
Compounds and methods for preventing or treating sensory hair cell death Feb 4, 2016 Issued
Menu